A Square Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 28 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -61.09%
- Profit Growth -48.60%
- Ebitda -257.91%
- Net Worth 31.89%
- Total Assets 5.85%
About A Square Remedies
A Square Remedies Private Limited (ASRPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 2011 and has a history of 14 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajaykumar Sheth, Jigar Jadeja, and Birju Shah serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2011PTC063575
-
Company No.
063575
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jan 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at A Square Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigar Jadeja
|
Director | 27-Dec-2024 | Current |
|
Ajaykumar Sheth
|
Director | 10-Jan-2011 | Current |
|
Birju Shah
|
Director | 31-Oct-2024 | Current |
Financial Performance of A Square Remedies.
A Square Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 61.09% decrease. The company also saw a substantial fall in profitability, with a 48.6% decrease in profit. The company's net worth Soared by an impressive increase of 31.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A Square Remedies?
In 2021, A Square Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sugen Pharma Private LimitedAjaykumar Sheth and Birju Shah are mutual person
-
Aarsh Remedies Private LimitedAjaykumar Sheth is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A Square Remedies?
Unlock and access historical data on people associated with A Square Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A Square Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A Square Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
